Home

Download

Statistics

Examples

Help

Contact

	Fusion Gene Summary
	Fusion Gene ORF analysis
	Fusion Genomic Features
	Fusion Protein Features
	Fusion Gene Sequence
	Fusion Gene PPI analysis
	Related Drugs
	Related Diseases

Fusion gene:CERS6-FAM102A (FusionGDB2 ID:15998)

Fusion Gene Summary for CERS6-FAM102A

Fusion gene summary

Fusion gene information	Fusion gene name: CERS6-FAM102A
	Fusion gene ID: 15998
		Hgene	Tgene
	Gene symbol	CERS6	FAM102A
	Gene ID	253782	399665
	Gene name	ceramide synthase 6	family with sequence similarity 102 member A
	Synonyms	CERS5\|LASS6	C9orf132\|EEIG1\|SYM-3A\|bA203J24.7
	Cytomap	2q24.3	9q34.11
	Type of gene	protein-coding	protein-coding
	Description	ceramide synthase 6LAG1 homolog, ceramide synthase 6longevity assurance homolog 6	protein FAM102AC230093N12Rikearly estrogen-induced gene 1 proteinsym-3 homolog A
	Modification date	20200313	20200320
	UniProtAcc	Q6ZMG9	Q5T9C2
	Ensembl transtripts involved in fusion gene	ENST00000305747, ENST00000392687,	ENST00000300434, ENST00000373084, ENST00000373095,
Fusion gene scores	* DoF score	18 X 12 X 8=1728	5 X 4 X 2=40
	# samples	22	5
	** MAII score	log2(22/1728*10)=-2.97352778863881 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0	log2(5/40*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0
Context	PubMed: CERS6 [Title/Abstract] AND FAM102A [Title/Abstract] AND fusion [Title/Abstract]
Most frequent breakpoint	CERS6(169417832)-FAM102A(130716204), # samples:1
Anticipated loss of major functional domain due to fusion event.

* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Partner	Gene	GO ID	GO term	PubMed ID
Hgene	CERS6	GO:0046513	ceramide biosynthetic process	17609214\|17977534

Fusion gene breakpoints across CERS6 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

Fusion gene breakpoints across FAM102A (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.

Source	Disease	Sample	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand
ChimerDB4	STAD	TCGA-BR-A4PD-01A	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-

Top

Fusion Gene ORF analysis for CERS6-FAM102A

Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.

ORF	Henst	Tenst	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand
5CDS-intron	ENST00000305747	ENST00000300434	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-
5CDS-intron	ENST00000305747	ENST00000373084	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-
5CDS-intron	ENST00000392687	ENST00000300434	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-
5CDS-intron	ENST00000392687	ENST00000373084	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-
In-frame	ENST00000305747	ENST00000373095	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-
In-frame	ENST00000392687	ENST00000373095	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-

ORFfinder result based on the fusion transcript sequence of in-frame fusion genes.

Henst

Tenst

Hgene

Hchr

Hbp

Hstrand

Tgene

Tchr

Tbp

Tstrand

Seq length
(transcript)

BP loci
(transcript)

Predicted start
(transcript)

Predicted stop
(transcript)

Seq length
(amino acids)

ENST00000305747

CERS6

chr2

169417832

ENST00000373095

FAM102A

chr9

130716204

4616

994

287

2002

571

ENST00000392687

CERS6

chr2

169417832

ENST00000373095

FAM102A

chr9

130716204

4229

607

140

1615

491

DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.

Henst	Tenst	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand	No-coding score	Coding score
ENST00000305747	ENST00000373095	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-	0.046202537	0.9537975
ENST00000392687	ENST00000373095	CERS6	chr2	169417832	+	FAM102A	chr9	130716204	-	0.047410753	0.9525893

Top

Fusion Genomic Features for CERS6-FAM102A

FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.

Hgene

Hchr

Hbp

Hstrand

Tgene

Tchr

Tbp

Tstrand

1-p

p (fusion gene breakpoint)

Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for CERS6-FAM102A

Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:169417832/chr9:130716204)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.

Main function of each fusion partner protein. (from UniProt)

Hgene	Tgene
CERS6 Q6ZMG9	FAM102A Q5T9C2
FUNCTION: Ceramide synthase that catalyzes formation of ceramide from sphinganine and acyl-CoA substrates, with high selectivity toward palmitoyl-CoA (hexadecanoyl-CoA; C16:0-CoA) as acyl donor (PubMed:17977534, PubMed:17609214, PubMed:23530041, PubMed:26887952, PubMed:31916624). Can use other acyl donors, but with less efficiency (By similarity). Ceramides generated by CERS6 play a role in inflammatory response (By similarity). Acts as a regulator of metabolism and hepatic lipid accumulation (By similarity). Under high fat diet, palmitoyl- (C16:0-) ceramides generated by CERS6 specifically bind the mitochondrial fission factor MFF, thereby promoting mitochondrial fragmentation and contributing to the development of obesity (By similarity). {ECO:0000250\|UniProtKB:Q8C172, ECO:0000269\|PubMed:17609214, ECO:0000269\|PubMed:17977534, ECO:0000269\|PubMed:23530041, ECO:0000269\|PubMed:26887952, ECO:0000269\|PubMed:31916624}.	FUNCTION: May play a role in estrogen action. {ECO:0000269\|PubMed:14605097}.

Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at
download page

* Minus value of BPloci means that the break pointn is located before the CDS.

- In-frame and retained protein feature among the 13 regional features.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Protein feature

Protein feature note

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

66_127

135

385.0

Region

Homeobox-like

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

66_127

135

393.0

Region

Homeobox-like

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

1_34

135

385.0

Topological domain

Lumenal

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

1_34

135

393.0

Topological domain

Lumenal

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

35_55

135

385.0

Transmembrane

Helical

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

35_55

135

393.0

Transmembrane

Helical

Tgene

FAM102A

chr2:169417832

chr9:130716204

ENST00000373084

157_268

243.0

Compositional bias

Note=Ser-rich

Tgene

FAM102A

chr2:169417832

chr9:130716204

ENST00000373095

157_268

385.0

Compositional bias

Note=Ser-rich

Tgene

FAM102A

chr2:169417832

chr9:130716204

ENST00000373084

2_145

243.0

Domain

C2 NT-type

- In-frame and not-retained protein feature among the 13 regional features.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Protein feature

Protein feature note

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

130_331

135

385.0

Domain

TLC

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

130_331

135

393.0

Domain

TLC

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

324_384

135

385.0

Topological domain

Cytoplasmic

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

324_384

135

393.0

Topological domain

Cytoplasmic

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

178_198

135

385.0

Transmembrane

Helical

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

205_225

135

385.0

Transmembrane

Helical

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

263_283

135

385.0

Transmembrane

Helical

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000305747

303_323

135

385.0

Transmembrane

Helical

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

178_198

135

393.0

Transmembrane

Helical

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

205_225

135

393.0

Transmembrane

Helical

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

263_283

135

393.0

Transmembrane

Helical

Hgene

CERS6

chr2:169417832

chr9:130716204

ENST00000392687

303_323

135

393.0

Transmembrane

Helical

Tgene

FAM102A

chr2:169417832

chr9:130716204

ENST00000373095

2_145

385.0

Domain

C2 NT-type

Top

Fusion Gene Sequence for CERS6-FAM102A

For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

>15998_15998_1_CERS6-FAM102A_CERS6_chr2_169417832_ENST00000305747_FAM102A_chr9_130716204_ENST00000373095_length(transcript)=4616nt_BP=994nt
AGGGCTGGTTCTGAAGCTTGGCGGCAGCCCCTACCTGCTGACCCACCGCCTCCGGGCGCACGGGAAGAGGACTGAGAGCCCTGAAACCCC
AGCGGGGCAGGAGCCAGCATTCTGAGCATGTGCGAGCCAGCCAGGGGGCTAGGGCGGATTTGGGGGGTCGACTTTAGGTCGTCGCCCTAA
GCGCAAAGCGAAAGAGCGGTGAGAGCAGGGGCGGGCGACACTCCCCGGAGCGGTGCCCCTGCGCCCAGGGCGCAGCGACTGCGCCCTGCC
CTGCGGGTGTGGGCGAGTTGGCCGCGTGTGTGCCTCGCTGTTTGACGCGAAGACGAGCCAATCAGGGCGGGCGGCCCGAGCTGCCATGTG
ACGGGCAAGGCGGCCCCTTTCCCCAGCGCGGCCAGAGGGAGGAGAGAACCGGGGCTCGCCGCGAGCCTTCGAGAGCAGCGGCCGCGGAGG
AGGCGGCGGCGGCGGGCGGGAGCAGCGGCGGCGGCGGCACAGGCTCGGGGCCAGCCGGGCGCGCATCCCCGGGCGCCCTGCGCGGTGGAG
AGCTTGGCGGGCTGCGGGTGCCGCAGGACAGGAGTGGACAAAGCAAGATGGCAGGGATCTTAGCCTGGTTCTGGAACGAGAGGTTTTGGC
TCCCGCACAATGTCACCTGGGCGGACCTGAAGAACACGGAGGAGGCCACCTTCCCGCAGGCTGAGGACCTCTATCTCGCTTTTCCCCTGG
CCTTCTGTATCTTCATGGTGCGGCTCATCTTCGAGAGATTTGTAGCCAAACCGTGCGCCATAGCCCTCAACATTCAGGCCAATGGACCAC
AAATTGCTCCGCCCAATGCCATTCTGGAAAAGGTCTTCACTGCAATTACAAAGCATCCTGATGAAAAGAGATTGGAAGGCCTCTCCAAGC
AACTGGACTGGGATGTTCGAAGCATTCAGCGCTGGTTTCGACAAAGACGCAATCAGGAGAAGCCAAGCACGCTGACGAGGTTCTGTGAGA
GCATGGAGGAGGTACAGGAGAACTGTGTGCGGTGGCGAAAGAGGTTCACCTTCGTGTGTAAGATGAGTGCTAACCCGGCCACCGGCCTGC
TGGACCCCTGTGTCTTCCGTGTGTCTGTGCGCAAGGAGCTGAAAGGCGGGAAGGCTTATTCCAAGCTGGGCTTCGCTGACTTGAACCTGG
CCGAGTTTGCGGGCTCGGGCTCCACGGTGCGCTGCTGCCTGCTCGAGGGATATGACACGAAGAACACTCGCCAGGACAACTCCATCCTTA
AGGTCACCATTGGTATGTTCCTGCTCTCTGGAGATCCCTGCTTCAAGACGCCACCATCGACTGCCAAGTCCATCTCCATCCCAGGCCAGG
ATTCCTCCCTGCAGCTGACGTGTAAGGGTGGTGGGACCAGCAGTGGGGGCAGCAGCACCAACTCCCTGACTGGGTCCCGGCCCCCCAAGG
CTCGGCCCACTATTCTCAGCTCAGGGCTGCCAGAGGAACCCGACCAGAACCTGTCCAGCCCTGAGGAGGTGTTCCACTCTGGCCACTCCC
GCAACTCCAGCTATGCCAGCCAGCAGTCCAAGATCTCCGGCTACAGCACAGAGCACTCGCGCTCCTCCAGCCTCTCAGACCTGACGCACC
GCCGCAACACGTCCACCAGCAGCAGCGCCTCTGGGGGCCTTGGCATGACCGTGGAGGGCCCTGAGGGCAGTGAGCGGGAGCACCGGCCCC
CGGAGAAGCCGCCGCGGCCACCCCGGCCCCTGCATCTGTCCGATCGCTCTTTCAGGCGGAAGAAGGACTCGGTGGAGAGCCACCCGACCT
GGGTGGACGACACGCGGATCGATGCGGATGCCATCGTGGAGAAGATCGTGCAGAGCCAGGATTTCACAGATGGCAGCAACACCGAGGACA
GCAACCTCCGGCTGTTCGTGAGCCGCGATGGCTCTGCCACGCTGAGCGGCATCCAGCTTGCCACCAGGGTCTCTTCTGGGGTCTACGAGC
CAGTTGTGATTGAAAGCCATTGAGGAGCAGGTGTCCGGGCTGGAGAAGAGTCCTGCTTTCTCTGGAGTCCAGACCTGTATCATTCCATGA
GGAACTTTCCCCTTCAGATCACCTCTGCGCCACATCTCATCCATGCCTCCTCCATGCACTCCAGTCCACACTCCCCGTAGCATCATTCCA
TTGCCCCTCCCATCCATGCTGGGACCCTCCTGGCCCACCAAGGCCCAGGCACCACTGTGAATATTCTCCTCTGAACCACTAGAGGGCAGG
CCAGGCAGGCCAGGCGGGCCCGTGCAGCTTGTGGGCAAGAAGGAGCTGGCAAGGACCGGCGCTGCTGGAGACTGACCCAGCCCTCTGGCT
GAGGACATGCAGCGGCTCCTAAATGTAGAGATGCCTGTGGCTGAGGGGGCCTCTCTACCTGTGTCCCCACTCACTCCAGGAGCACTGGCT
TTGGTCACGTCTTAGCAGCAGGGCCTTGCTCCGTTGTTCCCTTGCCCTGGTGGTGGGGGGGCCAGACCACCTCCGGAATCCTGCCACCTG
TGACTGTCTGACTGCTTAGTGCTTCAGCTGTCCCTTCCTTGTGTCCTGGGGGACCTGCTGGCGGCCTCTTCCTGGGAGCCATGACCTCAG
ACCCCACCCACACTCCAGATCGAGACCCCTGCCTCCCCCCGGCAAATGTCCTCCCGCTGCCTTGCAGCCTGCACTTTGCACATGCTCACC
CCCAGCACAGTCCCACTGGCCCCTCACCTCCCCTTCCCTGAGCTCCTTCCCAAGGACTCCTGGTCACTGCCTGCTGTGCAGTCAGAGGCC
CAGGGTCCAGCAGCCCGGCGGGAACGGGTGCTGCCTCTTCCTCCAGTTAGCTCCAGCTCAGGTCTGAGACCCGTGCTGAGAAAGGTCTGA
GCACCGACCGTGCCCTCTGCCCAGGGCTGGGTCCTGAGCAGCTGGTTTTCCTGCAGGAAGGTTGGAGCAAGCAAAGTCCTTCTCTGCCCT
CAGGGTCAGCTGCCCAGACTGGGGCGGATGCCAGAGAGGCAGGTGGGCTGTGGCTGGACTGGTCCGGAGCTGGCTTCCTTACCAGAAAAG
CCTCAGCCTTCCTCTGGAAGCATCCCCCGTTCTGGGCAAGGGGGAAGGGCTCCTTTAAGGGGTGTGCTTTCCCAGTGGGGAGCAGTCTGG
CCCTGCCCCCTACTAAAGCCTCTGCTCTCAGCACTTTCCCCCAAGTCCTTGTAACTTGCTTGAAGGTGGGTTCTGGCTGCCAGCCAGTCC
CTGGACAAACTCTCCTGCCCCTTTTAAATTTCACTCATTTTGTATAAACCCAGCAGGCTGGTGTTTACTTAGCCCTGTAGCTTTTTTCAT
TTTTTCTTTCCGTCTTTCTTCTTGAGTTCACGGTTCAATATTGCCTCCTCGCCCTGGTGAGGGGAGGTGCTGCTTTTCTGCCCCACCTGC
CGGCTGGTTCCAGCAGCGCTGGGGCCCAGCTGGGGGGCCGGGATGGGGGCTTCTCTCTCTGGGAGGGGTGCAGGTGCCCTCCCCAGGCTG
GGAGGGTTCCTTCCCTAGCTCCCCATCTGCCCCCGCTGGTGAGAGTTGGGCTTCTTGGTCTTGGAACTCCCTGGCATTGGGAACAGAGCA
TTTCCAGCATTTGTTGTTGTTTTACTCACCTAACCCTTAGAAAATGAATGTTAGAAGGTGCCTGCCGAGGCGGGACAGAGTGTTCGCTCG
CGCTGGAGAAGGCTCTGCTCAGCCCTGAGAGTCCCTTCCTGCCCCACCGATACTGGCACTTTAAAAAGGAAGCTGACCGCACAGTGTCCA
GACGAATTGGCCCCCAGAAGATGGGGAGTTCTGTCCTGCCCTTCTGTGTCTGCGTGACCTCACCCAGCCTAGGAGGGAGGTGCATTCAGG
GTAGATTTGCCTCTCATTCAAAGTTCTGGGGCTTTGGGTGGAAAACAGCCAGCTTTGGCGCTGTTGGGGAGACTCCTCCAGACCAGGAAC
CCCAGAAGGAGACAGAGCCTGCCACATCCTCCCACGCCAGGCCCTGGGCCAGGGTGATTGGACTGAGAATTTGGCCACAACCAAATTGAT
GCTGGCTGGAACCAGAGGCCAGAAAGCCTGGCCTTGTCCCCATGTGGGAGCCCTGTCCTCAGCCCTCTTGTCCCCTTGAGCTCAGTGAAT
TCCCACCAGGTGCCCACAGCTCCTGGACTTCAAATTCTATATATTGAGAGAGTTGGAGAGTATATCAGAGATATTTTTGGAAAGGAGTTG
GTCTATGCAATGTCAGTTTGGAATCTTCTTGAAAGTTTAATGTTTTTATTAGGAGATTTAAAGAAAATAAAGGTCTACAATATCTTTAGG
TTTTTTTTTTTTCCTGTTTACCGCACAAACTGACCACATGGCATGTCTATCAGGATGGAGGGTGTCCATGTTCTCCTCTGTCTTTAGGGA
GGTGATAAGGAGATGGGCGGAGGGGTGTTTTTTTCTTTGACTCCCCTCCTTTCTAACAGAATGTTGCCACCACTGCTTGAGTGGGCTGTG
TTTGTTCCTCTGTCCCAGCTTCTGTTGTAGAAAATAACATTGTTAGGGGAACTCAGGCTAGTGTCAGCGTCTTGGTTTGGGGAGAAAAAA

>15998_15998_1_CERS6-FAM102A_CERS6_chr2_169417832_ENST00000305747_FAM102A_chr9_130716204_ENST00000373095_length(amino acids)=571AA_BP=42
MAACVPRCLTRRRANQGGRPELPCDGQGGPFPQRGQREERTGARREPSRAAAAEEAAAAGGSSGGGGTGSGPAGRASPGALRGGELGGLR
VPQDRSGQSKMAGILAWFWNERFWLPHNVTWADLKNTEEATFPQAEDLYLAFPLAFCIFMVRLIFERFVAKPCAIALNIQANGPQIAPPN
AILEKVFTAITKHPDEKRLEGLSKQLDWDVRSIQRWFRQRRNQEKPSTLTRFCESMEEVQENCVRWRKRFTFVCKMSANPATGLLDPCVF
RVSVRKELKGGKAYSKLGFADLNLAEFAGSGSTVRCCLLEGYDTKNTRQDNSILKVTIGMFLLSGDPCFKTPPSTAKSISIPGQDSSLQL
TCKGGGTSSGGSSTNSLTGSRPPKARPTILSSGLPEEPDQNLSSPEEVFHSGHSRNSSYASQQSKISGYSTEHSRSSSLSDLTHRRNTST
SSSASGGLGMTVEGPEGSEREHRPPEKPPRPPRPLHLSDRSFRRKKDSVESHPTWVDDTRIDADAIVEKIVQSQDFTDGSNTEDSNLRLF

--------------------------------------------------------------
>15998_15998_2_CERS6-FAM102A_CERS6_chr2_169417832_ENST00000392687_FAM102A_chr9_130716204_ENST00000373095_length(transcript)=4229nt_BP=607nt
GCGGCCAGAGGGAGGAGAGAACCGGGGCTCGCCGCGAGCCTTCGAGAGCAGCGGCCGCGGAGGAGGCGGCGGCGGCGGGCGGGAGCAGCG
GCGGCGGCGGCACAGGCTCGGGGCCAGCCGGGCGCGCATCCCCGGGCGCCCTGCGCGGTGGAGAGCTTGGCGGGCTGCGGGTGCCGCAGG
ACAGGAGTGGACAAAGCAAGATGGCAGGGATCTTAGCCTGGTTCTGGAACGAGAGGTTTTGGCTCCCGCACAATGTCACCTGGGCGGACC
TGAAGAACACGGAGGAGGCCACCTTCCCGCAGGCTGAGGACCTCTATCTCGCTTTTCCCCTGGCCTTCTGTATCTTCATGGTGCGGCTCA
TCTTCGAGAGATTTGTAGCCAAACCGTGCGCCATAGCCCTCAACATTCAGGCCAATGGACCACAAATTGCTCCGCCCAATGCCATTCTGG
AAAAGGTCTTCACTGCAATTACAAAGCATCCTGATGAAAAGAGATTGGAAGGCCTCTCCAAGCAACTGGACTGGGATGTTCGAAGCATTC
AGCGCTGGTTTCGACAAAGACGCAATCAGGAGAAGCCAAGCACGCTGACGAGGTTCTGTGAGAGCATGGAGGAGGTACAGGAGAACTGTG
TGCGGTGGCGAAAGAGGTTCACCTTCGTGTGTAAGATGAGTGCTAACCCGGCCACCGGCCTGCTGGACCCCTGTGTCTTCCGTGTGTCTG
TGCGCAAGGAGCTGAAAGGCGGGAAGGCTTATTCCAAGCTGGGCTTCGCTGACTTGAACCTGGCCGAGTTTGCGGGCTCGGGCTCCACGG
TGCGCTGCTGCCTGCTCGAGGGATATGACACGAAGAACACTCGCCAGGACAACTCCATCCTTAAGGTCACCATTGGTATGTTCCTGCTCT
CTGGAGATCCCTGCTTCAAGACGCCACCATCGACTGCCAAGTCCATCTCCATCCCAGGCCAGGATTCCTCCCTGCAGCTGACGTGTAAGG
GTGGTGGGACCAGCAGTGGGGGCAGCAGCACCAACTCCCTGACTGGGTCCCGGCCCCCCAAGGCTCGGCCCACTATTCTCAGCTCAGGGC
TGCCAGAGGAACCCGACCAGAACCTGTCCAGCCCTGAGGAGGTGTTCCACTCTGGCCACTCCCGCAACTCCAGCTATGCCAGCCAGCAGT
CCAAGATCTCCGGCTACAGCACAGAGCACTCGCGCTCCTCCAGCCTCTCAGACCTGACGCACCGCCGCAACACGTCCACCAGCAGCAGCG
CCTCTGGGGGCCTTGGCATGACCGTGGAGGGCCCTGAGGGCAGTGAGCGGGAGCACCGGCCCCCGGAGAAGCCGCCGCGGCCACCCCGGC
CCCTGCATCTGTCCGATCGCTCTTTCAGGCGGAAGAAGGACTCGGTGGAGAGCCACCCGACCTGGGTGGACGACACGCGGATCGATGCGG
ATGCCATCGTGGAGAAGATCGTGCAGAGCCAGGATTTCACAGATGGCAGCAACACCGAGGACAGCAACCTCCGGCTGTTCGTGAGCCGCG
ATGGCTCTGCCACGCTGAGCGGCATCCAGCTTGCCACCAGGGTCTCTTCTGGGGTCTACGAGCCAGTTGTGATTGAAAGCCATTGAGGAG
CAGGTGTCCGGGCTGGAGAAGAGTCCTGCTTTCTCTGGAGTCCAGACCTGTATCATTCCATGAGGAACTTTCCCCTTCAGATCACCTCTG
CGCCACATCTCATCCATGCCTCCTCCATGCACTCCAGTCCACACTCCCCGTAGCATCATTCCATTGCCCCTCCCATCCATGCTGGGACCC
TCCTGGCCCACCAAGGCCCAGGCACCACTGTGAATATTCTCCTCTGAACCACTAGAGGGCAGGCCAGGCAGGCCAGGCGGGCCCGTGCAG
CTTGTGGGCAAGAAGGAGCTGGCAAGGACCGGCGCTGCTGGAGACTGACCCAGCCCTCTGGCTGAGGACATGCAGCGGCTCCTAAATGTA
GAGATGCCTGTGGCTGAGGGGGCCTCTCTACCTGTGTCCCCACTCACTCCAGGAGCACTGGCTTTGGTCACGTCTTAGCAGCAGGGCCTT
GCTCCGTTGTTCCCTTGCCCTGGTGGTGGGGGGGCCAGACCACCTCCGGAATCCTGCCACCTGTGACTGTCTGACTGCTTAGTGCTTCAG
CTGTCCCTTCCTTGTGTCCTGGGGGACCTGCTGGCGGCCTCTTCCTGGGAGCCATGACCTCAGACCCCACCCACACTCCAGATCGAGACC
CCTGCCTCCCCCCGGCAAATGTCCTCCCGCTGCCTTGCAGCCTGCACTTTGCACATGCTCACCCCCAGCACAGTCCCACTGGCCCCTCAC
CTCCCCTTCCCTGAGCTCCTTCCCAAGGACTCCTGGTCACTGCCTGCTGTGCAGTCAGAGGCCCAGGGTCCAGCAGCCCGGCGGGAACGG
GTGCTGCCTCTTCCTCCAGTTAGCTCCAGCTCAGGTCTGAGACCCGTGCTGAGAAAGGTCTGAGCACCGACCGTGCCCTCTGCCCAGGGC
TGGGTCCTGAGCAGCTGGTTTTCCTGCAGGAAGGTTGGAGCAAGCAAAGTCCTTCTCTGCCCTCAGGGTCAGCTGCCCAGACTGGGGCGG
ATGCCAGAGAGGCAGGTGGGCTGTGGCTGGACTGGTCCGGAGCTGGCTTCCTTACCAGAAAAGCCTCAGCCTTCCTCTGGAAGCATCCCC
CGTTCTGGGCAAGGGGGAAGGGCTCCTTTAAGGGGTGTGCTTTCCCAGTGGGGAGCAGTCTGGCCCTGCCCCCTACTAAAGCCTCTGCTC
TCAGCACTTTCCCCCAAGTCCTTGTAACTTGCTTGAAGGTGGGTTCTGGCTGCCAGCCAGTCCCTGGACAAACTCTCCTGCCCCTTTTAA
ATTTCACTCATTTTGTATAAACCCAGCAGGCTGGTGTTTACTTAGCCCTGTAGCTTTTTTCATTTTTTCTTTCCGTCTTTCTTCTTGAGT
TCACGGTTCAATATTGCCTCCTCGCCCTGGTGAGGGGAGGTGCTGCTTTTCTGCCCCACCTGCCGGCTGGTTCCAGCAGCGCTGGGGCCC
AGCTGGGGGGCCGGGATGGGGGCTTCTCTCTCTGGGAGGGGTGCAGGTGCCCTCCCCAGGCTGGGAGGGTTCCTTCCCTAGCTCCCCATC
TGCCCCCGCTGGTGAGAGTTGGGCTTCTTGGTCTTGGAACTCCCTGGCATTGGGAACAGAGCATTTCCAGCATTTGTTGTTGTTTTACTC
ACCTAACCCTTAGAAAATGAATGTTAGAAGGTGCCTGCCGAGGCGGGACAGAGTGTTCGCTCGCGCTGGAGAAGGCTCTGCTCAGCCCTG
AGAGTCCCTTCCTGCCCCACCGATACTGGCACTTTAAAAAGGAAGCTGACCGCACAGTGTCCAGACGAATTGGCCCCCAGAAGATGGGGA
GTTCTGTCCTGCCCTTCTGTGTCTGCGTGACCTCACCCAGCCTAGGAGGGAGGTGCATTCAGGGTAGATTTGCCTCTCATTCAAAGTTCT
GGGGCTTTGGGTGGAAAACAGCCAGCTTTGGCGCTGTTGGGGAGACTCCTCCAGACCAGGAACCCCAGAAGGAGACAGAGCCTGCCACAT
CCTCCCACGCCAGGCCCTGGGCCAGGGTGATTGGACTGAGAATTTGGCCACAACCAAATTGATGCTGGCTGGAACCAGAGGCCAGAAAGC
CTGGCCTTGTCCCCATGTGGGAGCCCTGTCCTCAGCCCTCTTGTCCCCTTGAGCTCAGTGAATTCCCACCAGGTGCCCACAGCTCCTGGA
CTTCAAATTCTATATATTGAGAGAGTTGGAGAGTATATCAGAGATATTTTTGGAAAGGAGTTGGTCTATGCAATGTCAGTTTGGAATCTT
CTTGAAAGTTTAATGTTTTTATTAGGAGATTTAAAGAAAATAAAGGTCTACAATATCTTTAGGTTTTTTTTTTTTCCTGTTTACCGCACA
AACTGACCACATGGCATGTCTATCAGGATGGAGGGTGTCCATGTTCTCCTCTGTCTTTAGGGAGGTGATAAGGAGATGGGCGGAGGGGTG
TTTTTTTCTTTGACTCCCCTCCTTTCTAACAGAATGTTGCCACCACTGCTTGAGTGGGCTGTGTTTGTTCCTCTGTCCCAGCTTCTGTTG

>15998_15998_2_CERS6-FAM102A_CERS6_chr2_169417832_ENST00000392687_FAM102A_chr9_130716204_ENST00000373095_length(amino acids)=491AA_BP=156
MRGGELGGLRVPQDRSGQSKMAGILAWFWNERFWLPHNVTWADLKNTEEATFPQAEDLYLAFPLAFCIFMVRLIFERFVAKPCAIALNIQ
ANGPQIAPPNAILEKVFTAITKHPDEKRLEGLSKQLDWDVRSIQRWFRQRRNQEKPSTLTRFCESMEEVQENCVRWRKRFTFVCKMSANP
ATGLLDPCVFRVSVRKELKGGKAYSKLGFADLNLAEFAGSGSTVRCCLLEGYDTKNTRQDNSILKVTIGMFLLSGDPCFKTPPSTAKSIS
IPGQDSSLQLTCKGGGTSSGGSSTNSLTGSRPPKARPTILSSGLPEEPDQNLSSPEEVFHSGHSRNSSYASQQSKISGYSTEHSRSSSLS
DLTHRRNTSTSSSASGGLGMTVEGPEGSEREHRPPEKPPRPPRPLHLSDRSFRRKKDSVESHPTWVDDTRIDADAIVEKIVQSQDFTDGS

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for CERS6-FAM102A

Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in
ChiPPI page.

Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)

Hgene

Hgene's interactors

Tgene

Tgene's interactors

- Retained PPIs in in-frame fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Still interaction with

- Lost PPIs in in-frame fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Interaction lost with

- Retained PPIs, but lost function due to frame-shift fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Interaction lost with

Top

Related Drugs for CERS6-FAM102A

Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)

Partner

Gene

UniProtAcc

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

Related Diseases for CERS6-FAM102A

Diseases associated with fusion partners.
(DisGeNet 4.0)

Partner

Gene

Disease ID

Disease name

# pubmeds

Source